Quarterly report pursuant to Section 13 or 15(d)

Fair Value Hierarchy

v2.4.0.8
Fair Value Hierarchy
6 Months Ended
Jun. 30, 2013
Fair Value Hierarchy [Abstract]  
Fair Value Hierarchy

2.  Fair Value Hierarchy

 

Under certain circumstances, beginning in the second quarter of 2013, Platinum-Montaur Life Sciences, Inc. (Montaur) has the right to convert all or any portion of the unpaid principal or unpaid interest accrued on any future draws under the Montaur credit facility.  Montaur’s option to convert future draws into common stock was determined to meet the definition of a liability, which is included in notes payable on the consolidated balance sheet.  The estimated fair value of Montaur’s conversion option is $943,000 at June 30, 2013 and will be measured on a recurring basis.  See Note 6.

 

There were no financial assets or liabilities measured at fair value on a recurring basis as December 31, 2012.  There were no Level 1 liabilities outstanding at any time during the three-month or six-month periods ended June 30, 2013 and 2012.  There were no transfers in or out of our Level 2 liabilities during the three-month or six-month periods ended June 30, 2013 or 2012.